Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)

1,502.30 -19.65 (-1.29%) At close: 03:46PM IST

Sun Pharmaceutical Industries Limited

Sun House
Plot No. 201 B/1 Western Express Highway Goregaon (East)
Mumbai 400063
India
91 22 4324 4324
https://www.sunpharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 41,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Dilip Shantilal Shanghvi	MD & Executive Director	54.53M	N/A	1955
Mr. Kalyanasundaram Subramanian	Director of Corporate Development	65.3M	N/A	1954
Mr. C. S. Muralidharan	Chief Financial Officer	38.89M	N/A	1963
Mr. Davinder Singh	Executive Vice-President of Global Operations	N/A	N/A	N/A
Mr. Dheeraj Prasad Sinha BE	EVP & Chief Information Officer	N/A	N/A	1971
Mr. Nimish Desai	Head of Investor Relations	N/A	N/A	N/A
Mr. Anoop Deshpande	Company Secretary & Compliance Officer	N/A	N/A	N/A
Mr. Suresh Kumar Rai	Chief Human Resources Officer	N/A	N/A	N/A
Mr. Kirti Wardhaman Ganorkar	Chief Executive Officer of India Business	N/A	N/A	1967
Mr. Aalok Dilip Shanghvi	Executive VP, Head of Emerging Markets, Global Generics R&D, Business Devp., and Whole Time Director	N/A	N/A	1984

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

Corporate governance

Sun Pharmaceutical Industries Limited’s ISS governance QualityScore as of 29 April 2024 is 2. The pillar scores are Audit: 4; Board: 2; Shareholder rights: 1; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.